Hannah Kopach
Nurse Practitioner · Johnstown, PANPI 1518679240
Payments from drug & device makers
Across 241 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$701
- AbbVie$643
- E.r. Squibb & Sons, L.L.C.$470
- AstraZeneca$324
- Lilly USA, LLC$317
- GSK$273
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,859100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 41 | $701 |
| AbbVie | 26 | $643 |
| E.r. Squibb & Sons, L.L.C. | 29 | $470 |
| AstraZeneca | 6 | $324 |
| Lilly USA, LLC | 17 | $317 |
| GSK | 20 | $273 |
| Novo Nordisk | 15 | $252 |
| Merck | 10 | $225 |
| Daiichi Sankyo Inc. | 9 | $212 |
| Exact Sciences | 9 | $168 |
| Tactile Systems Technology Inc | 4 | $147 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $108 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Boston Scientific | 2 | $95 |
| Amgen | 6 | $92 |
| Aimmune Therapeutics, Inc. | 5 | $80 |
| Johnson & Johnson | 2 | $73 |
| Acadia Pharmaceuticals Inc | 3 | $69 |
| Bayer | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 1 | $55 |
| Stryker | 1 | $51 |
| Abiomed | 2 | $38 |
| Lundbeck LLC | 2 | $35 |
| Boehringer Ingelheim | 2 | $33 |
| Verona Pharma, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| Cequr Corporation | 1 | $23 |
| Antares Pharma, Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Inari Medical, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$367
- BREZTRI$250
- UBRELVY$124
- NURTEC ODT$113
How this compares
$4,879 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 62 | $49,505 |
| OzempicSemaglutide | 38 | $44,449 |
| XareltoRivaroxaban | 27 | $22,585 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $17,144 |
| JardianceEmpagliflozin | 18 | $15,811 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $9,735 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,983 |
| Atorvastatin Calcium | 173 | $1,938 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,817 |
| Potassium Chloride | 62 | $1,646 |
| Levothyroxine Sodium | 85 | $1,224 |
| Ventolin HfaAlbuterol Sulfate | 21 | $1,150 |
| Metoprolol Succinate | 76 | $931 |
| Rosuvastatin Calcium | 48 | $831 |
| Sertraline Hcl | 90 | $795 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $701 | $49,50562 claims |
| Novo NordiskOzempic | $252 | $44,44938 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $273 | $26,87940 claims |
| Johnson & JohnsonXarelto | $73 | $22,58527 claims |
| Boehringer IngelheimJardiance | $33 | $15,81118 claims |
| AstraZenecaBreztri Aerosphere | $324 | $6,98311 claims |
| AbbVieSynthroid | $643 | $50517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Johnstown
- Pamela LorditchJohnstown$81K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.